CTRI/2024/02/062389尚未招募Unknown
Effectiveness and Safety of Amlodipine and Telmisartanin Treatment Naïve Hypertension: An EMR-basedRetrospective, Comparative Study - NI
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Treatment-naïve patients with essential or primary hypertension.
- •Patients who were prescribed amlodipine or telmisartan monotherapy as first line therapy.
排除标准
- •Patients with secondary hypertension.
- •Patients prescribed with any other antihypertensive drug
- •Patients prescribed with any combination of antihypertensive drugs
研究者
相似试验
尚未招募
4 期
Comparison between effect of two drugs- amlodipine and telmisartan on people with high blood pressure on their blood sugar levels,lipid rofile and renal profile.CTRI/2024/07/071545Midnapore medical college and hospital
已完成
不适用
Effect of combination therapy with amlodipine and atorvastatin on blood pressure varaiability, vascular function and renal function in hypertensive patients with chronic kidney diseaseHypertension with chronic kidney disease (CKD stage 1-4)JPRN-UMIN000009045Yokohama city university hospital50
进行中（未招募）
1 期
EFFICACY AND SAFETY OF AMLODIPINE USED AS ADD-ON THERAPY IN MODERATELY TO SEVERELY HYPERTENSIVE PATIENTS NOT ADEQUATELY CONTROLLED BY OLMESARTAN MEDOXOMIL 20 MG MONOTHERAPY. Eficacia y seguridad de amlodipino utilizado como terapìa adicional en pacientes con hipertensión moderada a severa no controlada adecuadamente con olmesartán medoxomilo 20 mg en monoterapiaessential hypertensionMedDRA version: 7.0Level: LLTClassification code 10015488EUCTR2005-000447-28-ESSankyo Pharma GmbH429
进行中（未招募）
不适用
EFFICACY AND SAFETY OF AMLODIPINE USED AS ADD-ON THERAPY IN MODERATELY TO SEVERELY HYPERTENSIVE PATIENTS NOT ADEQUATELY CONTROLLED BY OLMESARTAN MEDOXOMIL 20 MG MONOTHERAPYEUCTR2005-000447-28-DESankyo Pharma GmbH429
尚未招募
不适用
To study the effect of two medicines Amlodipine and Labetolol in controlling blood pressure in delivered patientsCTRI/2020/02/023236Jawahalal Nehru Institute of Postgraduate Medical Education and Research